Columnist Michelle Harlan details her three-step process for explaining what sickle beta-zero thalassemia is and how it ...

An imbalance in the gut microbiome, the group of bacteria and other microbes in the digestive tract, may drive chronic SCD ...

A protruding abdomen with sickle cell disease isn’t always a sign of a serious problem for patients, writes columnist.

Now home after a long hospitalization, columnist Mary Shaniqua worries about the long-term impact of her recent sickle cell ...

Young people with SCD living in areas with more air pollution are more likely to be hospitalized for acute chest syndrome, a ...

Wilson may not know what's causing his mystery symptom, but the sickle cell community makes him feel validated.

Researchers have used a noninvasive tool to detect small blood vessel disease in the brain of SCD patients, according to a ...

Scientists at NYU are teaming up with music artist Adekunle Gold on a campaign to improve the lives of people with sickle cell disease.

BEAM-101, a genetically modified cell therapy for sickle cell disease (SCD) that’s being tested in clinical trials, has been granted orphan drug status by the U.S. Food and Drug Administration (FDA).